Sharma Pooja, Plant Matthew, Lam Sheung Kwan, Chen Qing
Discovery Attribute Sciences, Amgen Research, Amgen Inc., Thousand Oaks, CA, 91320.
Discovery Attribute Sciences, Amgen Research, Amgen Inc., Cambridge, MA, 02141.
BBA Adv. 2021 Aug 5;1:100022. doi: 10.1016/j.bbadva.2021.100022. eCollection 2021.
The fundamental importance of membrane protein (MP) targets in central biological and cellular events has driven a marked increase in the use of membrane mimetics for exploring these proteins as therapeutic targets. The main challenge associated with biophysical analysis of membrane protein is the need for detergent extraction from the bilayer environment, which in many cases causes the proteins to become insoluble, unstable or display altered structure or activity. Recent technological advances have tried to limit the exposure of purified membrane protein to detergents. One such method involves the amphipathic co-polymer of styrene and maleic acid (SMA), which can release lipids and integral membrane proteins into water soluble native particles (or vesicles) termed SMALPs (Styrene Maleic Acid Lipid Particles). In this study, assay conditions that leverage SMA for membrane protein stabilization were developed to perform kinetic analysis of antibody binding to integral membrane protein and complexes in SMALPs in both purified and complex mixture settings using multiple biosensor platforms. To develop a robust and flexible platform using SMALPs technology, we optimized various SPR assay formats to analyze SMALPs produced with cell membrane pellets as well as whole cell lysates from the cell lines overexpressing membrane protein of interest. Here we emphasize the extraction of model membrane proteins of diverse architecture and function from native environments to encapsulate with SMALPs. Given the importance of selected membrane targets in central biological events and therapeutic relevance, MP-specific or tag-specific antibodies were used as a proof-of-principal to validate the SMALPs platform for ligand binding studies to support drug discovery or tool generation processes. MP-SMALPs that retain specific binding capability in multiple assay formats and biosensors, such as waveguide interferometry and surface plasmon resonance, would be a versatile platform for a wide range of downstream applications.
膜蛋白(MP)靶点在核心生物学和细胞事件中具有根本重要性,这推动了膜模拟物在将这些蛋白作为治疗靶点进行探索方面的使用显著增加。与膜蛋白生物物理分析相关的主要挑战在于需要从双层环境中用去污剂提取,在许多情况下这会导致蛋白变得不溶、不稳定或显示出结构或活性改变。最近的技术进步试图限制纯化的膜蛋白与去污剂的接触。一种这样的方法涉及苯乙烯和马来酸的两亲共聚物(SMA),它可以将脂质和整合膜蛋白释放到称为SMALPs(苯乙烯马来酸脂质颗粒)的水溶性天然颗粒(或囊泡)中。在本研究中,开发了利用SMA实现膜蛋白稳定化的检测条件,以使用多种生物传感器平台在纯化和复杂混合物设置下对抗体与整合膜蛋白及SMALPs中的复合物的结合进行动力学分析。为了使用SMALPs技术开发一个强大且灵活的平台,我们优化了各种SPR检测形式,以分析用细胞膜沉淀以及来自过表达感兴趣膜蛋白的细胞系的全细胞裂解物产生的SMALPs。在这里,我们强调从天然环境中提取具有不同结构和功能的模型膜蛋白并用SMALPs进行封装。鉴于所选膜靶点在核心生物学事件中的重要性和治疗相关性,使用MP特异性或标签特异性抗体作为原理验证来验证用于配体结合研究以支持药物发现或工具生成过程的SMALPs平台。在多种检测形式和生物传感器(如波导干涉测量和表面等离子体共振)中保留特异性结合能力的MP - SMALPs将是一个适用于广泛下游应用的通用平台。